Original Research
Published on 22 Feb 2024
Feasibility and tolerability of eribulin-based chemotherapy versus other chemotherapy regimens for patients with metastatic triple-negative breast cancer: a single-centre retrospective study
in Cancer Cell Biology

- 1,899 views